Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Safe and effective percutaneous ethanol injection therapy of 200 thyroid cysts

M. Halenka, D. Karasek, J. Schovanek, Z. Frysak

. 2020 ; 164 (2) : 161-167. [pub] 20190329

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc21014151

INTRODUCTION: Ultrasound-guided percutaneous ethanol injection therapy (US-PEIT) is a minimally invasive procedure that may be performed as an alternative to surgery for the treatment of recurrent symptomatic thyroid cysts for which simple aspiration failed. The present study aimed at assessing US-PEIT in a large cohort of patients, identifying factors influencing treatment outcome. METHODS: Retrospective analysis of 193 patients with 200 thyroid cysts who underwent US-PEIT in 2004-2018. RESULTS: The initial median cyst volume was 8.5 mL [5.5-16.0]; median final volume at 12 months after the completion of therapy was 0.5 mL [0.2-1.3]. A Volume Reduction Rate (VRR) of 95.0% [86.7-98.0] was achieved. For successful US-PEIT, relatively small total amount of ethanol was needed, on average corresponding to 20.0% [16.7-28.6] of the initial cyst volume. VRR positively correlated with the initial cyst volume and negatively with the presence of complex cyst. Multiple regression analysis showed the presence of complex cyst as an independent predictor of treatment efficacy. CONCLUSION: US-PEIT of thyroid cysts of all sizes was very successful with using total amounts of ethanol, corresponding to ≈20% of the initial cyst volume.

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21014151
003      
CZ-PrNML
005      
20210528092855.0
007      
ta
008      
210504s2020 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2019.007 $2 doi
035    __
$a (PubMed)30945701
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Halenka, Milan $7 xx0047393 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology
245    10
$a Safe and effective percutaneous ethanol injection therapy of 200 thyroid cysts / $c M. Halenka, D. Karasek, J. Schovanek, Z. Frysak
504    __
$a Literatura
520    9_
$a INTRODUCTION: Ultrasound-guided percutaneous ethanol injection therapy (US-PEIT) is a minimally invasive procedure that may be performed as an alternative to surgery for the treatment of recurrent symptomatic thyroid cysts for which simple aspiration failed. The present study aimed at assessing US-PEIT in a large cohort of patients, identifying factors influencing treatment outcome. METHODS: Retrospective analysis of 193 patients with 200 thyroid cysts who underwent US-PEIT in 2004-2018. RESULTS: The initial median cyst volume was 8.5 mL [5.5-16.0]; median final volume at 12 months after the completion of therapy was 0.5 mL [0.2-1.3]. A Volume Reduction Rate (VRR) of 95.0% [86.7-98.0] was achieved. For successful US-PEIT, relatively small total amount of ethanol was needed, on average corresponding to 20.0% [16.7-28.6] of the initial cyst volume. VRR positively correlated with the initial cyst volume and negatively with the presence of complex cyst. Multiple regression analysis showed the presence of complex cyst as an independent predictor of treatment efficacy. CONCLUSION: US-PEIT of thyroid cysts of all sizes was very successful with using total amounts of ethanol, corresponding to ≈20% of the initial cyst volume.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a cysty $x diagnostické zobrazování $x farmakoterapie $7 D003560
650    _2
$a ethanol $x terapeutické užití $7 D000431
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a injekce do léze $7 D015552
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a nemoci štítné žlázy $x diagnostické zobrazování $x farmakoterapie $7 D013959
650    _2
$a výsledek terapie $7 D016896
650    _2
$a ultrasonografie $7 D014463
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Karásek, David $7 stk2007415300 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology
700    1_
$a Schovánek, Jan $7 xx0227659 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology
700    1_
$a Fryšák, Zdeněk $7 xx0082612 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 164, č. 2 (2020), s. 161-167
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30945701 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20210504 $b ABA008
991    __
$a 20210521152816 $b ABA008
999    __
$a ok $b bmc $g 1657564 $s 1134539
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 164 $c 2 $d 161-167 $e 20190329 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20210504

Find record

Citation metrics

Archiving options